TNFRSF13C and Stroke: It is tempting to speculate that combined with a lipid-lowering strategy, anti-BAFFR antibody treatment has potential to even more effectively reduce progression of atherosclerosis and reduce the lethal complications of atherosclerosis-related myocardial infarction and stroke.